Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Official URL: https://fevir.net/resources/Evidence/267233 | Version: 1.0.0-ballot3 | ||||
| Standards status: Informative | Computable Name: NCT03421379_primaryOutcomeMeasure_0_OG001 | ||||
| Other Identifiers: FEvIR Object Identifier: FEvIR Object Identifier#267233, FEvIR Linking Identifier: NCT03421379-primaryOutcomeMeasure-0--OG001, OID:2.16.840.1.113883.4.642.40.44.22.239 | |||||
Copyright/Legal: Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse). |
|||||
This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.
version: 14; Last updated: 2026-09-02 17:15:21+0000
Profile: NonComparativeEvidence
ArtifactPublicationStatus: Active
identifier: FEvIR Object Identifier/267233, FEvIR Linking Identifier/NCT03421379-primaryOutcomeMeasure-0--OG001, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.22.239
version: 1.0.0-ballot3
name: NCT03421379_primaryOutcomeMeasure_0_OG001
title: Percentage of Participants Achieving Treatment Success During Controlled Insulin-Induced Hypoglycemia at Pre-dose up to 30 minutes post each glucagon administration for Glucagon Hydrochloride Solution in NCT03421379
citeAs:
Percentage of Participants Achieving Treatment Success During Controlled Insulin-Induced Hypoglycemia at Pre-dose up to 30 minutes post each glucagon administration for Glucagon Hydrochloride Solution in NCT03421379 [Database Entry: FHIR Evidence Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 267233. Revised 2026-09-02. Available at: https://fevir.net/resources/Evidence/267233. Computable resource at: https://fevir.net/resources/Evidence/267233#json.
status: Active
date: 2026-11-05 14:34:28+0000
author: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter:
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
copyright:
Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).
description:
This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.
variableDefinition
description:
Glucagon Hydrochloride Solution
note: ,
Outcome Measure Population Description: All randomized participant who completed both treatment visits and had evaluable treatment success data.
Outcome Measure Denominator Units: Participants
variableRole: Population
observed: A single dose of 1 mg glucagon hydrochloride solution was administered IM (Identifier: ClinicalTrials.gov Outcome Measurement Group Id/OG001)
variableDefinition
variableRole: Outcome
statistic
statisticType: Number (see protocol for details)
quantity: 100 percentage of participants
SampleSizes
KnownDataCount 68